Title |
No Biological Evidence of XMRV in Blood or Prostatic Fluid from Prostate Cancer Patients
|
---|---|
Published in |
PLOS ONE, May 2012
|
DOI | 10.1371/journal.pone.0036073 |
Pubmed ID | |
Authors |
Ramon Mendoza, Robert H. Silverman, Eric A. Klein, A. Dusty Miller |
Abstract |
XMRV (xenotropic murine leukemia virus-related virus) was initially discovered in association with prostate cancer and later with chronic fatigue syndrome (CFS). Its association with CFS is now largely discredited, and current results support a laboratory origin for XMRV with no reproducible evidence for infection of humans. However, some results indicating the presence of XMRV in prostate cancer are difficult to attribute to sample contamination. Here we have sought biological evidence that might confirm the presence of XMRV in prostate cancer samples previously having tested positive. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 20% |
United Kingdom | 1 | 20% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | 4% |
Denmark | 1 | 4% |
Unknown | 21 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 4 | 17% |
Student > Master | 3 | 13% |
Professor | 2 | 9% |
Other | 2 | 9% |
Student > Bachelor | 2 | 9% |
Other | 7 | 30% |
Unknown | 3 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 30% |
Agricultural and Biological Sciences | 3 | 13% |
Biochemistry, Genetics and Molecular Biology | 2 | 9% |
Unspecified | 1 | 4% |
Mathematics | 1 | 4% |
Other | 4 | 17% |
Unknown | 5 | 22% |